MedPath

CAPRELSA 300 MG COMPRIMIDOS RECUBIERTOS CON PELICULA

CAPRELSA 300 MG COMPRIMIDOS RECUBIERTOS CON PELICULA

Commercialized
Register Number

11749002

Prescription Type

Diagnóstico Hospitalario

Authorization Date

Feb 29, 2012

Dosage Form

COMPRIMIDO RECUBIERTO CON PELÍCULA

Route: VÍA ORAL

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number11749002
EMA Approved
Yes

Drug Classification

Generic
No
Orphan
No
Biosimilar
No
Commercialized
Yes
CIMA AEMPS Classification

INGREDIENTS (1)

VANDETANIBActive
Quantity: 300 mg
Name: VANDETANIB

ATC CLASSIFICATION (3)

L01E
L01EX
L01EX04

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.